Genomic alterations underlie a pan-cancer metabolic shift associated with tumour hypoxia
Altered metabolism is a hallmark of cancer. However, the role of genomic changes in metabolic genes driving the tumour metabolic shift remains to be elucidated. Here, we have investigated the genomic and transcriptomic changes underlying this shift across ten different cancer types.A systematic pan-...
Auteurs principaux: | Haider, S, McIntyre, A, van Stiphout, R, Winchester, L, Wigfield, S, Harris, A, Buffa, F |
---|---|
Format: | Journal article |
Langue: | English |
Publié: |
BioMed Central
2016
|
Documents similaires
-
The tumour hypoxia induced non-coding transcriptome.
par: Choudhry, H, et autres
Publié: (2016) -
Gene expression signatures as biomarkers of tumour hypoxia
par: Harris, B, et autres
Publié: (2015) -
Assessment of tumour hypoxia for prediction of response to therapy and cancer prognosis.
par: Jubb, A, et autres
Publié: (2010) -
The BET inhibitor JQ1 selectively impairs tumour response to hypoxia and downregulates CA9 and angiogenesis in triple negative breast cancer (TNBC)
par: Harris, A, et autres
Publié: (2016) -
Metabolic Shift and Hyperosmolarity Underlie Age-Related Macular Degeneration
par: Laurent Schwartz, et autres
Publié: (2024-09-01)